Stibbe advises Forbion Capital Partners

Matter
NL Law
Expertise
Corporate and M&A Tax Healthcare and Life Sciences EU and Competition Law Civil-Law Notary

Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.

Archived - LUX city visual 14

Stibbe advises Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.

Key contact(s)

Team